Ulirch Haupts

Company: Navigo Proteins GmbH

Job title: Chief Scientific Officer & Managing Director

Seminars:

Affilin Molecules as a New Modality for Radiotheranostics 11:30 am

Outlining scaffold-based ligands to provide an alternative to peptides and antibodies Molecular engineering allows modulation of in-vivo PK and BioDRead more

day: Day 2 - P&T Track AM